Daphné Benteyn

1.3k total citations
19 papers, 1.1k citations indexed

About

Daphné Benteyn is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Daphné Benteyn has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 16 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Daphné Benteyn's work include Immunotherapy and Immune Responses (17 papers), CAR-T cell therapy research (16 papers) and RNA Interference and Gene Delivery (10 papers). Daphné Benteyn is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), CAR-T cell therapy research (16 papers) and RNA Interference and Gene Delivery (10 papers). Daphné Benteyn collaborates with scholars based in Belgium, United States and France. Daphné Benteyn's co-authors include Kris Thielemans, Carlo Heirman, Aude Bonehill, An M. T. Van Nuffel, Bart Neyns, Jurgen Corthals, Sofie Wilgenhof, Karine Breckpot, Ivan Van Riet and Sarah Maenhout and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Daphné Benteyn

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daphné Benteyn Belgium	13	791	664	463	196	77	19	1.1k
Sonja Van Meirvenne Belgium	15	707 0.9×	516 0.8×	345 0.7×	215 1.1×	54 0.7×	19	1.0k
Annette Arnold Germany	12	827 1.0×	262 0.4×	522 1.1×	198 1.0×	51 0.7×	17	1.2k
Assaf Marcus United States	9	988 1.2×	424 0.6×	430 0.9×	57 0.3×	181 2.4×	9	1.2k
Nikhil Khatwani United States	5	327 0.4×	659 1.0×	206 0.4×	144 0.7×	131 1.7×	6	924
Stephanie Dorta‐Estremera United States	13	664 0.8×	315 0.5×	350 0.8×	54 0.3×	57 0.7×	30	875
Cornell Allen United States	13	257 0.3×	378 0.6×	274 0.6×	218 1.1×	31 0.4×	22	693
Beatrice Thurner Germany	5	1.4k 1.8×	653 1.0×	532 1.1×	99 0.5×	20 0.3×	5	1.5k
Sachiko Okamoto Japan	15	482 0.6×	578 0.9×	644 1.4×	285 1.5×	18 0.2×	37	1.2k
So Jung Kong South Korea	10	434 0.5×	236 0.4×	324 0.7×	133 0.7×	120 1.6×	16	681
Linda Pan United States	11	895 1.1×	444 0.7×	522 1.1×	106 0.5×	19 0.2×	23	1.1k

Countries citing papers authored by Daphné Benteyn

Since Specialization

Citations

This map shows the geographic impact of Daphné Benteyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphné Benteyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphné Benteyn more than expected).

Fields of papers citing papers by Daphné Benteyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphné Benteyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphné Benteyn. The network helps show where Daphné Benteyn may publish in the future.

Co-authorship network of co-authors of Daphné Benteyn

This figure shows the co-authorship network connecting the top 25 collaborators of Daphné Benteyn. A scholar is included among the top collaborators of Daphné Benteyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daphné Benteyn. Daphné Benteyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Lint, Sandra Van, Dries Renmans, Katrijn Broos, et al.. (2016). Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells. Cancer Immunology Research. 4(2). 146–156. 101 indexed citations

Benteyn, Daphné, Carlo Heirman, Kris Thielemans, & Aude Bonehill. (2016). Engineering WT1-Encoding mRNA to Increase Translational Efficiency in Dendritic Cells. Methods in molecular biology. 1428. 115–123. 1 indexed citations

Four, Stephanie Du, Sarah Maenhout, Daphné Benteyn, et al.. (2016). Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion. Cancer Immunology Immunotherapy. 65(6). 727–740. 37 indexed citations

Benteyn, Daphné, Carlo Heirman, Aude Bonehill, Kris Thielemans, & Karine Breckpot. (2014). mRNA-based dendritic cell vaccines. Expert Review of Vaccines. 14(2). 161–176. 133 indexed citations

Benteyn, Daphné, An M. T. Van Nuffel, Sofie Wilgenhof, & Aude Bonehill. (2014). Single-Step Antigen Loading and Maturation of Dendritic Cells Through mRNA Electroporation of a Tumor-Associated Antigen and a TriMix of Costimulatory Molecules. Methods in molecular biology. 1139. 3–15. 11 indexed citations

Wilgenhof, Sofie, Jurgen Corthals, An M. T. Van Nuffel, et al.. (2014). Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases. Cancer Immunology Immunotherapy. 64(3). 381–388. 63 indexed citations

Wilgenhof, Sofie, An M. T. Van Nuffel, Daphné Benteyn, et al.. (2013). A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients. Annals of Oncology. 24(10). 2686–2693. 170 indexed citations

Benteyn, Daphné, Sébastien Anguille, Sandra Van Lint, et al.. (2013). Design of an Optimized Wilms’ Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo. Molecular Therapy — Nucleic Acids. 2. e134–e134. 40 indexed citations

Nuffel, An M. T. Van, Daphné Benteyn, Sofie Wilgenhof, et al.. (2013). Loading of dendritic cells for immunotherapy. ISBT Science Series. 8(1). 161–164. 1 indexed citations

10.

Benteyn, Daphné, An M. T. Van Nuffel, Sofie Wilgenhof, et al.. (2013). Characterization of CD8⁺T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL). BioMed Research International. 2013. 1–8. 68 indexed citations

11.

Nuffel, An M. T. Van, Sandra Tuyaerts, Daphné Benteyn, et al.. (2012). Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens. Journal of Immunological Methods. 377(1-2). 23–36. 17 indexed citations

12.

Nuffel, An M. T. Van, Daphné Benteyn, Sofie Wilgenhof, et al.. (2012). Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma Patients. Molecular Therapy. 20(5). 1063–1074. 80 indexed citations

13.

Neyns, Bart, Sofie Wilgenhof, An M. T. Van Nuffel, et al.. (2012). Phase IB study on combined intradermal (ID) and intravenous (IV) administration of autologous mRNA electroporated dendritic cells (DC) as a single-agent cellular immunotherapy or combined with ipilimumab.. Journal of Clinical Oncology. 30(15_suppl). 2507–2507. 2 indexed citations

14.

Lint, Sandra Van, Cleo Goyvaerts, Sarah Maenhout, et al.. (2012). Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy. Cancer Research. 72(7). 1661–1671. 172 indexed citations

15.

Nuffel, An M. T. Van, Daphné Benteyn, Sofie Wilgenhof, et al.. (2011). Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient. Cancer Immunology Immunotherapy. 61(7). 1033–1043. 53 indexed citations

16.

Neyns, Bart, Sofie Wilgenhof, An M. T. Van Nuffel, et al.. (2011). A phase I clinical trial on the combined intravenous (IV) and intradermal (ID) administration of autologous TriMix-DC cellular therapy in patients with pretreated melanoma (TriMixIDIV).. Journal of Clinical Oncology. 29(15_suppl). 2519–2519. 12 indexed citations

17.

Wilgenhof, Sofie, An M. T. Van Nuffel, Jurgen Corthals, et al.. (2011). Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma. Journal of Immunotherapy. 34(5). 448–456. 118 indexed citations

18.

Wilgenhof, Sofie, Daphné Benteyn, Jurgen Corthals, et al.. (2010). Clinical outcome following therapeutic vaccination with autologous mRNA electroporated dendritic cell (DC) vaccines in patients with advanced melanoma.. Journal of Clinical Oncology. 28(15_suppl). 8547–8547. 2 indexed citations

19.

Wilgenhof, Sofie, Daphné Benteyn, Carlo Heirman, et al.. (2009). Therapeutic vaccination with an autologous TriMix-Dendritic cell vaccine combined with sequential interferon alfa-2b in patients with advanced melanoma. Journal of Clinical Oncology. 27(15_suppl). 9024–9024. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact